Fast-track your regulatory research.

Regulatory answers you can verify and defend.

Ask a question to see a cited answer.

420+

Official regulators

175M+

Regulatory documents

1,513

Regulation databases

Jurisdictions

General AI vs RegAffairs AI

Better regulatory answers than ChatGPT or Claude.

General AI

Answers from training data
Uses any website, even personal blogs
Can quote rules that have since changed
Can't trace a claim to its source

RegAffairs AI

Official regulatory datasets only
Searched exhaustively
Current, refreshed every week
Every claim cited to its source

Question: Give the harmonised CLP classification of formaldehyde: hazard statements, pictograms and signal word for my SDS.

ChatGPT/Gemini/ClaudeWrong

“Carc. 1B, H350: May cause cancer. Muta. 2, H341: Suspected of causing genetic defects. Acute Tox. 3*, H301: Toxic if swallowed. Acute Tox. 3*, H311: Toxic in contact with skin. Acute Tox. 3*, H331: Toxic if inhaled. Skin Corr. 1B, H314: Causes severe skin burns and eye damage. Skin Sens. 1, H317: May cause an allergic skin reaction.”

RegAffairs AICited

For formaldehyde (Index No 605-001-00-5, EC 200-001-8, CAS 50-00-0), the harmonised classification in force since 1 May 2026 carries the signal word Danger, pictograms GHS08, GHS06 and GHS05, and hazard statements H350, H341, H330, H302, H314 and H317, plus the supplemental statement EUH071. … The new entry has Acute Tox. 2, H330 (inhalation) and Acute Tox. 4, H302 (oral).

Read the full answer →Check the official source ↗

Question: What regulated price ceilings apply to Aurobindo’s levetiracetam product in its thirty-tablet presentation in Brazil?

ChatGPT/Gemini/ClaudeWrong

“I could confirm the regulated price ceilings for only one 30-tablet Aurobindo levetiracetam box: the 250 mg strength. … Factory price ceiling (PF): R$ 35,90, at São Paulo's 12% state tax rate (ICMS) … Maximum consumer price (PMC): R$ 47,95 … The 750 mg product page didn't show any prices, so I can't give you a confirmed ceiling for that box.”

RegAffairs AICited

Aurobindo has two 30-tablet levetiracetam presentations on the CMED price list, the 250 mg and the 750 mg film-coated tablets. … At 12% ICMS, the 250 mg ×30 ceilings are R$ 38,50 (PF), R$ 51,65 (PMC) and R$ 30,88 (PMVG). For the 750 mg ×30 they are R$ 194,41, R$ 260,79 and R$ 155,94.

Read the full answer →Check the official source ↗

Question: Is BPA still allowed in food contact materials in the EU, and when do the transition periods end?

ChatGPT/Gemini/ClaudeWrong

“The general transition for reusable articles also ended on 20 July 2026. Qualifying reusable articles first placed on the market under the transitional provisions may continue to be marketed through the distribution chain, subject to the applicable conditions, until 20 January 2029.”

RegAffairs AICited

No. As a general rule, BPA can no longer be used to make food contact materials in the EU. … The 20 July 2027 sell-through date for general repeat-use articles was added. Before the correction, Article 12(3) gave only 20 January 2029, which applies to the professional equipment category.

Read the full answer →Check the official source ↗

Question: Can I use silver (CI 77820) as a colorant in a nail polish sold in the EU?

ChatGPT/Gemini/ClaudeWrong

“Yes, with conditions. Under the EU Cosmetics Regulation (EC) 1223/2009, silver (CI 77820) is listed in Annex IV as an allowed colorant. Product types: It has no field-of-application restriction, so nail polish is covered. Nano form: Only the non-nano form is allowed. Nano silver is not authorised as a colorant, and SCCS opinions on nano/colloidal silver were negative.”

RegAffairs AICited

No, not since 1 May 2026. Silver (CI 77820) is still an allowed EU colorant, but only as micron-sized powder (particle diameter over 100 nm and under 1 mm). It is limited to lip products and eye shadow, at no more than 0.2 % in the ready-for-use product. Nail polish is not one of the permitted product types, so a nail polish coloured with silver cannot be placed on the EU market.

Read the full answer →Check the official source ↗

Question: Do Class A non-sterile, non-measuring medical devices need a licence from CDSCO in India?

ChatGPT/Gemini/ClaudeWrong

“No manufacturing licence is needed, but you still have to register with CDSCO. Manufacture: A 2022 amendment to the Medical Devices Rules, 2017 exempts Class A non-sterile, non-measuring devices from the manufacturing licence (Form MD-5). … Import: The exemption covers manufacturing. As far as I know, importers still need an import licence (Form MD-15).”

RegAffairs AICited

No. CDSCO's FAQ says Class A medical devices that are both non-sterile and non-measuring do not need an import or manufacturing licence under the Medical Devices Rules, 2017 (MDR-2017) to be marketed in India. They are exempt from Chapters IV, V, VII, VIII and XI of the Rules. They still have to be registered and labelled correctly.

Read the full answer →Check the official source ↗

Question: What is the EU maximum residue level for acetamiprid in honey?

ChatGPT/Gemini/ClaudeWrong

“As of 20 August 2025 the limit is 0.3 mg/kg, set by Regulation (EU) 2025/1212. I could not confirm whether a later increase has been adopted. … Draft increase: Draft measure 2025-1931 would raise it to 1 mg/kg, based on EFSA's 2025 opinion. I found no evidence it has been published as law.”

RegAffairs AICited

The EU MRL for acetamiprid in honey and other apiculture products (Annex I code 1040000) is 1 mg/kg. It was set by Commission Regulation (EU) 2026/876 and has applied since 12 May 2026. … Regulation (EU) 2025/1212: raised to 0.3 mg/kg after an Article 6(1) application that covered "honey and other apiculture products".

Read the full answer →Check the official source ↗

Question: What are the EU binding occupational exposure limit and biological limit value for lead?

ChatGPT/Gemini/ClaudeWrong

“Under Directive (EU) 2024/869, which amended the Chemical Agents Directive 98/24/EC: Binding OEL: 0.03 mg/m³ of inhalable lead and its compounds, as an 8-hour time-weighted average. Binding BLV: 15 µg Pb per 100 ml of blood. Transitional values: until 31 Dec 2028, Member States may apply an OEL of 0.05 mg/m³ and a BLV of 30 µg/100 ml.”

RegAffairs AICited

For lead and its inorganic compounds, the EU binding occupational exposure limit is 0.03 mg/m³ (8-hour TWA, inhalable fraction). The binding biological limit value is 30 µg Pb/100 ml blood until 31 December 2028, dropping to 15 µg Pb/100 ml blood from 1 January 2029. These limits were set by Directive (EU) 2024/869, and Member States had to transpose it by 9 April 2026.

Read the full answer →Check the official source ↗

Question: Is creosote still approved as a biocidal active substance for wood preservation in the EU, and until when?

ChatGPT/Gemini/ClaudeWrong

“Yes. Creosote is still approved in the EU, but only for wood preservation (product-type 8). As far as I know, the approval runs until 31 October 2027. … Legal basis: Commission Implementing Regulation (EU) 2022/1950 renewed the approval. Candidate for substitution: creosote is on this list, so the approval is time-limited and comes with strict conditions.”

RegAffairs AICited

Yes. Creosote (EC 232-287-5, CAS 8001-58-9) is still approved under the EU Biocidal Products Regulation for product type 8 (wood preservatives). The current approval runs until 31 October 2029. … Approval period: from 1 May 2013 to 31 October 2029. Current approval act: Commission Implementing Regulation (EU) 2022/1950.

Read the full answer →Check the official source ↗

Ask your own question →Already use Claude or ChatGPT? Add RegAffairs AI to it →

A real answer

Every answer shows its work.

Q.01Is TiO₂ still harmonised as Carc. 2 under CLP?

Researched · 6 steps · 48sexpand ▾

No. The harmonised Carc. 2 entry from Regulation (EU) 2020/217 [1] was annulled by the General Court on 23 November 2022 [2] and no longer appears in Annex VI. The appeal is pending, so treat the position as stable but not final.

Sources · 2collapse ▴

[1]Delegated Regulation (EU) 2020/217, OJ L 44EUR-Lex

[2]Judgment T-279/20 & T-288/20, ¶¶105–112Curia

Cited to the paragraph

Claims link to the exact annex entry or judgment paragraph, not just a document title.

The method is on the page

Every search and document the agent read, shown right on the page.

Nothing invented

Answers come only from the indexed text. Where the record is silent, the answer says so.

The work

Hours of cross-referencing, in minutes.

Status and scope checks

Is it still listed, restricted or authorised, and what changed after the last amendment or ruling? History, current text and case law in one answer.

Multi-market comparisons

One product, several territories. Get only the differences that matter: thresholds, triggers, language duties and who holds the registration.

Duty-holder and deadline questions

Who notifies, by when, and under which article. Determined from the operative text rather than a summary of it.

“

It is the first tool where I can hand the answer straight to legal. The citations go to the paragraph, and the trail shows exactly how it got there.

Head of regulatory affairs · Pilot customer

“

Last time we did this research it took the team a fortnight. The first answer came back in under a minute, with every source attached.

Regulatory affairs director · Pilot customer

Compare

Two other ways to get the answer.

A consultant takes a week and sends an invoice. An in-house build takes a year. RegAffairs AI gives you a cited answer in a minute.

RegAffairs AI vs consultants

The same rigour, without the retainer.

Consultants are indispensable for judgement calls. Status checks, scope questions and cross-market comparisons are the research underneath. An answer in a minute, cited to source, beats a week and an invoice.

RegAffairs AI vs in-house AI

Skip the twelve-month build.

You could point an LLM at your own document store. Then you own the sourcing, the refresh, the citation layer and the maintenance. Or you start today.

All comparisons →

Never used for training

Your questions and uploads stay yours, always.

EU data residency

Processed and stored in the EU by default.

Every step shown

The full research trail sits with each answer.